agilon health (NYSE:AGL) Raised to "Buy" at Citigroup

agilon health (NYSE:AGL - Get Free Report) was upgraded by analysts at Citigroup from a "neutral" rating to a "buy" rating in a report issued on Friday, MarketBeat reports. The brokerage presently has a $5.00 price objective on the stock, up from their previous price objective of $3.25. Citigroup's price target would suggest a potential upside of 30.21% from the stock's previous close.

AGL has been the topic of a number of other reports. Cowen reiterated a "hold" rating on shares of agilon health in a report on Tuesday, April 15th. Royal Bank of Canada lifted their price target on agilon health from $3.00 to $3.50 and gave the company an "outperform" rating in a report on Wednesday, February 26th. Stifel Nicolaus boosted their target price on agilon health from $2.00 to $3.00 and gave the stock a "hold" rating in a research note on Wednesday, February 26th. Sanford C. Bernstein upgraded agilon health from a "market perform" rating to an "outperform" rating and boosted their target price for the stock from $3.30 to $8.50 in a research note on Tuesday, April 8th. Finally, Needham & Company LLC restated a "hold" rating on shares of agilon health in a research note on Friday, March 21st. Two analysts have rated the stock with a sell rating, twelve have issued a hold rating and four have issued a buy rating to the company's stock. Based on data from MarketBeat.com, agilon health currently has an average rating of "Hold" and an average price target of $4.81.

agilon health Trading Down 1.5 %

AGL traded down $0.06 during trading on Friday, hitting $3.84. 3,762,836 shares of the stock were exchanged, compared to its average volume of 4,835,802. The firm has a 50 day simple moving average of $4.20 and a 200 day simple moving average of $3.14. The firm has a market cap of $1.59 billion, a price-to-earnings ratio of -4.09 and a beta of 0.38. agilon health has a 1 year low of $1.50 and a 1 year high of $7.73. The company has a debt-to-equity ratio of 0.06, a quick ratio of 1.29 and a current ratio of 1.29.

Institutional Inflows and Outflows

A number of hedge funds and other institutional investors have recently added to or reduced their stakes in AGL. Capital International Investors raised its holdings in shares of agilon health by 72.0% during the 4th quarter. Capital International Investors now owns 22,331,873 shares of the company's stock worth $42,431,000 after acquiring an additional 9,346,295 shares during the period. Millennium Management LLC raised its holdings in agilon health by 187.8% in the 4th quarter. Millennium Management LLC now owns 7,212,525 shares of the company's stock valued at $13,704,000 after buying an additional 4,706,357 shares during the period. Algert Global LLC raised its holdings in agilon health by 1,042.7% in the 4th quarter. Algert Global LLC now owns 2,108,687 shares of the company's stock valued at $4,007,000 after buying an additional 1,924,157 shares during the period. Charles Schwab Investment Management Inc. raised its holdings in agilon health by 49.2% in the 4th quarter. Charles Schwab Investment Management Inc. now owns 4,541,549 shares of the company's stock valued at $8,629,000 after buying an additional 1,498,524 shares during the period. Finally, JPMorgan Chase & Co. raised its holdings in agilon health by 326.4% in the 3rd quarter. JPMorgan Chase & Co. now owns 1,415,419 shares of the company's stock valued at $5,563,000 after buying an additional 1,083,492 shares during the period.

About agilon health

agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc and changed its name to agilon health, inc.